Alopecia areata during interferon alpha-2b/ribavirin therapy [2]

Dermatology

Volumn 205, Issue 2-3, 2002, Pages 300-301

  Agesta, N ^a   Zabala, R ^a   Diaz Perez J L ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

Alopecia areata; Alopecia areata, drug induced; Interferon 2b; Ribavirin

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; RIBAVIRIN; TRIAMCINOLONE;

ADULT; ALOPECIA AREATA; ANAMNESIS; ANEMIA; BULLOUS SKIN DISEASE; CASE REPORT; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; DRUG WITHDRAWAL; DYSGEUSIA; FEMALE; HAIR DISEASE; HAIR LOSS; HEREDITY; HERPES LABIALIS; HUMAN; HUMORAL IMMUNITY; HYPERTRICHOSIS; INJECTION SITE; LABORATORY TEST; LETTER; LEUKOPENIA; LICHEN PLANUS; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; TREATMENT OUTCOME; VITILIGO;

ALOPECIA AREATA; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MIDDLE AGED; RIBAVIRIN;

EID: 0036977428     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065841     Document Type: Letter

References (19)

1. Madani S, Shapiro J: Alopecia areata update. J Am Acad Dermatol 2000;42:549-566.
2. Umlas J, Harken DE: Warfarin induced alopecia. Cutis 1988;42:63-64.
3. Cerottini JP, Panizzon RG, de Viragh PA: Multifocal alopecia areata during systemic cyclosporine A therapy. Dermatology 1999;198:415-417.
4. Misciali C, Peluso AM, Cameli N, Tosti A: Occurrence of alopecia areata in a patient receiving systemic cyclosporine A. Arch Dermatol 1996;132:843-844.
5. McMillen R, Duvic M: Alopecia areata occurring in sisters after administration of rifampicin. J Am Acad Dermatol 2001;44:142-143.
6. Kubota T, Ishikura T, Jibiki I: Three cases of alopecia areata induced by zotepine. Acta Neurol 1993;15:200-203.
7. Geletko SM, Segarra M, Mikolich DJ: Alopecia associated with zidovudine therapy. Pharmacotherapy 1996;16:79-81.
8. Chang LW, Liranzo M, Bergfeld WF: Cutaneous side effects associated with interferon alpha therapy: A review. Cutis 1995;56:144.
9. Fattovich G, Giustina G, Favarato S, Ruol A: A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996;24:38-47.
10. Dusheiko G: Side effects of alpha interferon in chronic hepatitis C. Hepatology 1997;26(suppl 1):112S-121S.
11. Sookoian S, Neglia V, Castaño G, Frider B, Kien MC, Chohuela E: High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus. Arch Dermatol 1999;135:1000-1001.
12. Flemine CJ, Mackie RM: Alpha interferon-induced hair discoloration. Br J Dermatol 1996;135:337-338.
13. Kadayifcilar S, Boyacioglu S, Kart H, Gursoy M, Aydin P: Ocular complications with high-dose interferon alpha in chronic active hepatitis. Eye 1999;13(pt 2):241-246.
14. Ozdogan M, Gur G, Kadayifcilar S, Boyacioglu S, Ozgur O, Teletar H: An unusual adverse effect of interferon: Hypertrichosis of the eyelashes. J Interferon Cytokine Res 2000;20:633-634.
15. Tosti A, Misciali C, Bardazzi F: Telogen effluvium due to recombinant interferon-alpha 2b. Dermatology 1992;184:124-125.
16. Lang AM, Norland AM, Schuneman RL, Tope WD: Localized interferon alfa-2b-induced alopecia. Arch Dermatol 1999;135:1126-1128.
17. Primo J, Merino C, Gómez Belda AB: Vitiligo y alopecia areata en pacientes con hepatitis crónica C tratados con interferon alfa asociado o no a ribavirina. Gastroenterol Hepatol 2000;23:362-363.
18. Kernland KH, Hunziker T: Alopecia areata induced by interferon alpha? Dermatology 1999;198:418-419.
19. Schalm SW, Hansen BE, Chemello L, Bellobuono A, Brower JT, Weiland O, Cavalletto L, Schvarez R, Ideo G, Alberti A: Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. J Hepatol 1997;26:961-966.